Focus Group Interview Study on Patient Experiences and Satisfaction
NCT ID: NCT04625842
Last Updated: 2024-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2020-09-01
2021-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project
NCT06152419
Nurse-led Follow-up Care for Head and Neck Cancer Patients
NCT01167179
Effects of High-intensity Training Compared to Resistance Training in Cancer Patients Undergoing Radiotherapy
NCT03252821
International Study to Evaluate Two Programs of Support for Patients With Advanced Cancer and Their Families
NCT04626349
Effectiveness of a Modern Educational Intervention in Breast Cancer Patients
NCT03351075
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* What elements of care (ie infrastructure, interpersonal contact, information, communication) are good to the opinion of patients and family members?
* What elements of care can be improved?
* What are priorities in improvement of the care for patients and families?
* What actions could possibly be taken in order to improve the care for future patients?
Because the radiotherapy ward exists of 3 clusters, one per type of treatment conducted, the investigators will perform 6 focus group interviews with patients (3 in the French, and 3 in the Dutch language) and 6 focus group interviews with family members (3 in the French, and 3 in the Dutch language).
Investigators will collect sex, main diagnosis (of patients), age and nationality of all participants at the beginning of each focus group interview. They will transcribe all interviews verbatim and analyze them in Nvivo software as provided by the VUB. Participant characteristics will be analyzed by descriptive statistics.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient focus group
Patients who received radiation treatment
Focus group interview
Group interview with patients who received radiation treatment
Family focus group
Family of patients who received radiation treatment
Focus group interview
Group interview with patients who received radiation treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Focus group interview
Group interview with patients who received radiation treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Dutch and French speaking
* Start date of treatment max 6 months before inclusion
* Estimated sample size: 5-8 x 6 patients
* All family members (+18) of patients who were treated for cancer, receiving radiotherapy, and followed thereafter in the UZ Brussel
* Dutch and French speaking
* Start date of treatment of patient max 6 months before inclusion
* Estimated sample size: 5-8 x 6 family members
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitair Ziekenhuis Brussel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mark De Ridder
Professor in oncology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UZ Brussel
Brussels, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-087
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.